Leading pharma companies are setting targets for reducing their greenhouse gas emissions, and reporting on their progress in meeting them. That’s according to a new study we at Oxford PharmaGenesis conducted in collaboration with researchers from the University of Oxford. But when it comes to reporting on supply chain emissions, more collaboration is needed – and the time is now.
17th March 2023
The NHS faces many challenges when it comes to service efficiencies
7th December 2022
Professor Gino Martini, CEO of the Precision Health Technologies Accelerator (PHTA Ltd), explains how Birmingham is providing the collaborative space to simultaneously drive innovation in pharma, and tackle health inequality.
30th November 2022
Post-pandemic, we have been forced to rethink the way in which medicines information is disseminated and consumed.
25th November 2022
For businesses operating in the pharmaceutical industry, patient safety is paramount and, when it comes to the labelling of products, devices or solutions used for medical purposes, clear, consistent and highly accurate labels are essential.
15th November 2022
Kate Downey talks about changing career direction and embracing patient engagement
6th September 2022
To get the full picture ethnographic specialists Naked Eye and healthcare agency VCCP are treating patients as individuals
6th September 2022
Rare diseases (RDs) or orphan diseases, by definition, are conditions that affect a small number of individuals. The exact number of RDs is unknown, but it is estimated to be approximately 6000-8000.
7th July 2022
